Ada Yonath, a pioneering Israeli chemist whose groundbreaking research illuminated the structure and function of the ribosome, died on Monday at the age of 87. The Weizmann Institute of Science near Tel Aviv, where she spent much of her career, confirmed her passing but did not provide further details.
Yonath’s scientific work addressed a central question in molecular biology: the detailed three-dimensional structure of the ribosome, the cellular machinery responsible for assembling the proteins essential to life. Her decades-long pursuit of this goal was initially met with skepticism, with some experts dismissing it as a futile effort. Nonetheless, her persistence and innovative approach eventually earned her a share of the 2009 Nobel Prize in Chemistry.
Beginning in the 1970s, Yonath sought to determine the ribosome’s structure through X-ray crystallography, a technique that reveals atomic arrangements by analyzing crystallized molecules. Because ribosomes are large, flexible, and dynamic, many believed they could not be crystallized. Yonath defied this consensus by studying ribosomes from extremophile bacteria—organisms adapted to harsh environments—on the assumption their ribosomes might be more stable. She also developed specialized freezing techniques to preserve delicate ribosomal crystals for analysis.
Her meticulous efforts produced increasingly detailed images of the ribosome through the 1980s and 1990s. Her work converged with that of Venkatraman Ramakrishnan, a structural biologist of Indian British-American background, and Thomas Steitz, an American biochemist. Together, their collective research culminated in high-resolution imagery of the ribosome at the start of the 21st century, a breakthrough that advanced understanding of how ribosomes read genetic information and link amino acids to form proteins.
The Nobel Committee credited their work for clarifying fundamental aspects of ribosome function and enabling the design of new antibiotics, a critical development amid rising global antibiotic resistance. By revealing exactly how antibiotics bind to bacterial ribosomes without affecting human ribosomes, Yonath’s research paved the way for more effective and targeted drug therapies.
Born Ada Esther Lifshitz on June 22, 1939, in Jerusalem under British Mandate rule, she was the elder of two sisters in a family of Polish immigrant parents. After her father’s death when she was 11, her family faced economic hardship. She excelled academically, attending an elite high school and later earning degrees in chemistry and biophysics from Hebrew University in Jerusalem. Yonath completed her doctorate in X-ray crystallography at the Weizmann Institute and conducted postdoctoral research in the United States before establishing Israel’s first protein crystallography lab there in 1970.
Despite funding challenges and professional doubts, she secured long-term collaboration with Germany’s Max Planck Research Unit in Hamburg, where she simultaneously led ribosome research from 1986 to 2004. Utilizing synchrotron-generated X-rays, she and her teams conducted over 25,000 experiments to capture the ribosome’s structure.
Yonath’s work extended beyond pure science to practical medical applications, offering critical insights in the fight against infectious diseases. By clarifying how antibiotics disrupt bacterial protein synthesis, her discoveries informed the development of new drugs to combat evolving bacterial strains.
In her Nobel acceptance speech, Yonath reflected on the early skepticism she faced and drew inspiration from nature, noting how polar bears maintain stable ribosomes during hibernation. She also spoke of inspiring future generations, including her granddaughter, who showed a keen interest in her work.
Ada Yonath’s legacy endures in the fields of molecular biology and medicine, marking her as a trailblazer in the quest to understand life at the molecular level and to harness that knowledge to improve human health.